The dendritic cell life cycle

Cell Cycle

Volumn 8, Issue 23, 2009, Pages 3816-3821

  Granucci, Francesca ^a   Zanoni, Ivan ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Apoptosis; CD14; Dendritic cells; NFAT; Smooth LPS

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CALCINEURIN; CALCIUM ION; CASPASE 9; CD14 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CYTOCHROME C; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELOID DIFFERENTIATION FACTOR 88; NUCLEAR RECEPTOR NUR77; PHOSPHOLIPASE C GAMMA2; PROTEIN BCL 2; PROTEIN MD 2; PROTEIN P35; PROTEIN TYROSINE KINASE; SECONDARY LYMPHOID TISSUE CHEMOKINE; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 2; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; AUTOIMMUNITY; B LYMPHOCYTE; CALCIUM CELL LEVEL; CELL CYCLE; CELL CYCLE REGULATION; CELL DEATH; CELL MIGRATION; CELL SURFACE; CELL SURVIVAL; DENDRITIC CELL; DNA BINDING; DOWN REGULATION; HOMEOSTASIS; IMMUNE RESPONSE; LYMPH NODE; LYMPHOCYTE SUBPOPULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER T CELL; NONHUMAN; PERIPHERAL LYMPHOCYTE; PHAGOCYTOSIS; PHENOTYPE; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

EID: 74849119430     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.23.9998     Document Type: Review

References (58)

1. Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2007; 7:19-30.
2. Zitvogel L. Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J Exp Med 2002; 195:9-14.
3. Steinman RM. Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation. Mt Sinai J Med 2001; 68:106-66.
4. Ricciardi-Castagnoli P, Granucci F. Opinion: Interpretation of the complexity of innate immune responses by functional genomics. Nat Rev Immunol 2002; 2:881-9.
5. Huang Q, Liu D, Majewski P, Schulte LC, Korn JM, Young RA, et al. The plasticity of dendritic cell responses to pathogens and their components. Science 2001; 294:870-5.
6. Everson MP, McDuffie DS, Lemak DG, Koopman WJ, McGhee JR, Beagley KW. Dendritic cells from different tissues induce production of different T cell cytokine profiles. J Leukoc Biol 1996; 59:494-8.
7. Henri S, Vremec D, Kamath A, Waithman J, Williams S, Benoist C, et al. The dendritic cell populations of mouse lymph nodes. J Immunol 2001; 167:741-8.
8. Ohl L, Mohaupt M, Czeloth N, Hintzen G, Kiafard Z, Zwirner J, et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 2004; 21:279-88.
9. Gunn MD, Kyuwa S, Tam C, Kakiuchi T, Matsuzawa A, Williams LT, et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 1999; 189:451-60.
10. Ato M, Stager S, Engwerda CR, Kaye PM. Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Nat Immunol 2002; 3:1185-91.
11. Faure-Andre G, Vargas P, Yuseff MI, Heuze M, Diaz J, Lankar D, et al. Regulation of dendritic cell migration by CD74, the MHC class II-associated invariant chain. Science 2008; 322:1705-10.
12. Granucci F, Zanoni I, Ricciardi-Castagnoli P. Central role of dendritic cells in the regulation and deregulation of immune responses. Cell Mol Life Sci 2008; 65:1683-97.
13. Matsue H, Takashima A. Apoptosis in dendritic cell biology. J Dermatol Sci 1999; 20:159-71.
14. Wang J, Zheng L, Lobito A, Chan FK, Dale J, Sneller M, et al. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 1999; 98:47-58.
15. Fields ML, Sokol CL, Eaton-Bassiri A, Seo S, Madaio MP, Erikson J. Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells. J Immunol 2001; 167:2370-8.
16. Chen M, Wang YH, Wang Y, Huang L, Sandoval H, Liu YJ, et al. Dendritic cell apoptosis in the maintenance of immune tolerance. Science 2006; 311:1160-4.
17. Stranges PB, Watson J, Cooper CJ, Choisy-Rossi CM, Stonebraker AC, Beighton RA, et al. Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity. Immunity 2007; 26:629-41.
18. Kamath AT, Henri S, Battye F, Tough DF, Shortman K. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 2002; 100:1734-41.
19. Zanoni I, Ostuni R, Capuano G, Collini M, Caccia M, Ronchi AE, et al. CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation. Nature 2009.
20. Hogan PG, Chen L, Nardone J, Rao A. Transcriptional regulation by calcium, calcineurin and NFAT. Genes Dev 2003; 17:2205-32.
21. Crabtree GR, Olson EN. NFAT signaling: choreographing the social lives of cells. Cell 2002; 109:67-79.
22. Kiani A, Rao A, Aramburu J. Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity 2000; 12:359-72.
23. Serfling E, Klein-Hessling S, Palmetshofer A, Bopp T, Stassen M, Schmitt E. NFAT transcription factors in control of peripheral T cell tolerance. Eur J Immunol 2006; 36:2837-43.
24. Xanthoudakis S, Viola JP, Shaw KT, Luo C, Wallace JD, Bozza PT, et al. An enhanced immune response in mice lacking the transcription factor NFAT1. Science 1996; 272:892-5.
25. Schuh K, Kneitz B, Heyer J, Bommhardt U, Jankevics E, Berberich-Siebelt F, et al. Retarded thymic involution and massive germinal center formation in NF-ATp-deficient mice. Eur J Immunol 1998; 28:2456-66.
26. Latinis KM, Norian LA, Eliason SL, Koretzky GA. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J Biol Chem 1997; 272:31427-34.
27. Li-Weber M, Laur O, Krammer PH. Novel Egr/ NF-AT composite sites mediate activation of the CD95 (APO-1/Fas) ligand promoter in response to T cell stimulation. Eur J Immunol 1999; 29:3017-27.
28. Xiao S, Matsui K, Fine A, Zhu B, Marshak-Rothstein A, Widom RL, et al. FasL promoter activation by IL-2 through SP1 and NFAT but not Egr-2 and Egr-3. Eur J Immunol 1999; 29:3456-65.
29. Rengarajan J, Mittelstadt PR, Mages HW, Gerth AJ, Kroczek RA, Ashwell JD, et al. Sequential involvement of NFAT and Egr transcription factors in FasL regulation. Immunity 2000; 12:293-300.
30. Chuvpilo S, Jankevics E, Tyrsin D, Akimzhanov A, Moroz D, Jha MK, et al. Autoregulation of NFATc1/A expression facilitates effector T cells to escape from rapid apoptosis. Immunity 2002; 16:881-95.
31. Kondo E, Harashima A, Takabatake T, Takahashi H, Matsuo Y, Yoshino T, et al. NF-ATc2 induces apoptosis in Burkitt's lymphoma cells through signaling via the B cell antigen receptor. Eur J Immunol 2003; 33:1-11.
32. + regulatory T cells to Nur77-induced apoptosis promotes allograft survival. PLoS One 2008; 3:2321.
33. Calnan BJ, Szychowski S, Chan FK, Cado D, Winoto A. A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity 1995; 3:273-82.
34. Weih F, Ryseck RP, Chen L, Bravo R. Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/ Fas ligand pathway. Proc Natl Acad Sci USA 1996; 93:5533-8.
35. Lee SL, Wesselschmidt RL, Linette GP, Kanagawa O, Russell JH, Milbrandt J. Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B (Nur77). Science 1995; 269:532-5.
36. Li H, Kolluri SK, Gu J, Dawson MI, Cao X, Hobbs PD, et al. Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science 2000; 289:1159-64.
37. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91:479-89.
38. Li P, Nijhawan D, Wang X. Mitochondrial activation of apoptosis. Cell 2004; 116:57-9.
39. Moll UM, Marchenko N, Zhang XK. p53 and Nur77/TR3 - transcription factors that directly target mitochondria for cell death induction. Oncogene 2006; 25:4725-43.
40. Beutler B, Jiang Z, Georgel P, Crozat K, Croker B, Rutschmann S, et al. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol 2006; 24:353-89.
41. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282:2085-8.
42. Foster SL, Medzhitov R. Gene-specific control of the TLR-induced inflammatory response. Clin Immunol 2009; 130:7-15.
43. Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R. TRAM couples endocytosis of Tolllike receptor 4 to the induction of interferon-beta. Nat Immunol 2008; 9:361-8.
44. Kagan JC, Medzhitov R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 2006; 125:943-55.
45. Haziot A, Ferrero E, Kontgen F, Hijiya N, Yamamoto S, Silver J, et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 1996; 4:407-14.
46. Lee HK, Dunzendorfer S, Soldau K, Tobias PS. Double-stranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity 2006; 24:153-63.
47. Jersmann HP. Time to abandon dogma: CD14 is expressed by non-myeloid lineage cells. Immunol Cell Biol 2005; 83:462-7.
48. Jiang Z, Georgel P, Du X, Shamel L, Sovath S, Mudd S, et al. CD14 is required for MyD88-independent LPS signaling. Nat Immunol 2005; 6:565-70.
49. Moore KJ, Andersson LP, Ingalls RR, Monks BG, Li R, Arnaout MA, et al. Divergent response to LPS and bacteria in CD14-deficient murine macrophages. J Immunol 2000; 165:4272-80.
50. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454:428-35.
51. Dellis O, Rossi AM, Dedos SG, Taylor CW. Counting functional inositol 1,4,5-trisphosphate receptors into the plasma membrane. J Biol Chem 2008; 283:751-5.
52. 2+ entry through plasma membrane IP3 receptors. Science 2006; 313:229-33.
53. Suzuki KG, Fujiwara TK, Sanematsu F, Iino R, Edidin M, Kusumi A. GPI-anchored receptor clusters transiently recruit Lyn and Galpha for temporary cluster immobilization and Lyn activation: single-molecule tracking study 1. J Cell Biol 2007; 177:717-30.
54. 2+ signaling: single-molecule tracking study 2. J Cell Biol 2007; 177:731-42.
55. Paulick MG, Bertozzi CR. The glycosylphosphatidylinositol anchor: a complex membrane-anchoring structure for proteins. Biochemistry 2008; 47:6991-7000.
56. Wadachi R, Hargreaves KM. Trigeminal nociceptors express TLR-4 and CD14: a mechanism for pain due to infection. J Dent Res 2006; 85:49-53.
57. Genth-Zotz S, von Haehling S, Bolger AP, Kalra PR, Wensel R, Coats AJ, et al. The anti-CD14 antibody IC14 suppresses ex vivo endotoxin stimulated tumor necrosis factor-alpha in patients with chronic heart failure. Eur J Heart Fail 2006; 8:366-72.
58. Kakihara T, Fujii M, Uchiyama M, Fuita S, Koyama M, Fukuda T, et al. Non-X histiocytoma, similar to fibrous histiocytoma, in an infant. Pathol Int 1995; 45:452-6.